Call for Abstract
11th World Congress and Expo on Cell & Stem Cell Research, will be organized around the theme “The Novel Stem Cell Research: It is not growing It Is Exploding”
Stem Cell Conference 2019 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Stem Cell Conference 2019
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Stem cells: An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type, and from which certain other kinds of cell arise by differentiation. Stem cells have the ability to differentiate into specific cell types. The two defining characteristics of a stem cell are perpetual self-renewal and the ability to differentiate into a specialized adult cell type. There are two major classes of stem cells: pluripotent that can become any cell in the adult body, and multipotent that are restricted to becoming a more limited population of cells.
- Track 1-1Induced Pluripotent Stem Cells
- Track 1-2Adult Stem Cells
- Track 1-3Tissue Stem Cells
- Track 1-4Application of Stem Cell
- Track 1-5Embryonic Stem Cells
- Track 1-6Epigenetics And Cancer Stem Cells
- Track 1-7Genomic Analysis And Molecular Basis of Cancer
Stem cell therapy is a type of cell therapy in which therapeutic efficacy exclusively attributed to the potency (function) of donor stem cells, presented in any quantity and purity. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
- Track 2-1Stem cell Injection Treatment
- Track 2-2Somatic Cell Therapy
- Track 2-3Pluripotent Stem Cell Based Cancer Therapy
- Track 2-4Neural Stem Cells Therapy
- Track 2-5Stem cell Therapy For Corneal Regeneration In The Eye
- Track 2-6Cardiac Stem Cell Therapeutics
Self-reestablishment and multiplication of foundational microorganism populaces is controlled, to some degree, by affectation of apoptosis. The quantity of foundational microorganisms is thusly a harmony between those lost to separation/apoptosis and those increased through multiplication. Apoptosis of immature microorganisms is accepted to be a dynamic procedure which changes because of natural conditions.
- Track 3-1Genomic Analysis And Molecular Basis of Cancer
- Track 3-2Apoptosis And Haematopoietic Stem Cells
- Track 3-3Novel Therapeutics
- Track 3-4Epigenetics And Cancer Stem Cells
- Track 3-5Specific Cancer Immunotherapy
- Track 3-6Ubiquitination Pathways For Cancer Therapy
- Track 3-7Translational Studies For Cancer Stem Cell-Based Therapies
- Track 3-8Specific Cancer Immunotherapy
- Track 3-9Inflammatory Diseases And Cancer
- Track 3-10Cancer Stem Cells And Impaired Apoptosis
- Track 3-11Enantioselectivity And Chiral Complexing In Cancer Therapy
Stem cell transplantation, sometimes referred to as bone marrow transplant, is a procedure that replaces unhealthy blood-forming cells with healthy cells. Stem cell transplants commonly are used to treat Leukemia and lymphoma, cancers that affect the blood and lymphatic system.
- Track 4-1Allogeneic Bone Marrow Transplantation
- Track 4-2Hematopoietic Stem Cell Transplantation
- Track 4-3Epithelial Transplantation
- Track 4-4Haploidentical Stem Cell Transplantation
- Track 4-5Transplantation In Primary Immunodeficiency
- Track 4-6Retinal Stem Cell Transplantation
- Track 4-7Myelodysplastic syndrome and drug therapy
Cell signaling mediated by morphogens is essential to coordinate growth and patterning, two key processes that govern the formation of a complex multi-cellular organism. During growth and patterning, cells are specified by both quantitative and directional information. While quantitative information regulates cell proliferation and differentiation, directional information is conveyed in the form of cell polarities instructed by local and global cues.
- Track 5-1Biochemical Signalling Pathway
- Track 5-2Initial Work In Science Signaling
- Track 5-3Immune Signaling
- Track 5-4Modulation of Hard-To-Target Tumor Cell Signaling
- Track 5-5Mesenchymal Stem Cell Activation Mechanism And Signalling
Embryonic stem (ES) cells are cells derived from the early embryo that can be propagated indefinitely in the primitive undifferentiated state while remaining pluripotent; they share these properties with embryonic germ (EG) cells. Candidate Embryonic stem and embryonic germ cell lines from the human blastocyst and embryonic gonad can differentiate into multiple types of somatic cell.
- Track 6-1Molecular Alterations During Female Reproductive Aging
- Track 6-2Role of Sperm DNA Integrity In Fertility
- Track 6-3Fertilization And Infertility
- Track 6-4Embryo Implantation
- Track 6-5Role of Macrophages In The Placenta
- Track 6-6Factors of Human Implantation
- Track 6-7Stimulus Trigerred Acquisition of Pluripotency (STAP)
Regeneration is the process of renewal, restoration, and growth that makes genomes, cells, organisms, and ecosystems resilient to natural fluctuations or events that cause disturbance or damage. Therapeutics is the branch of medicine concerned with the treatment of disease and the action of remedial agents.
- Track 7-1Biofabrication And Bone Tissue
- Track 7-2Regeneration Manufacturing Challenges for Regenerative Medicine
- Track 7-3Cardiac Progenitor Cells
- Track 7-4Mesenchymal Cells
- Track 7-5Nanotechnology In The Regeneration of Complex Tissues
- Track 7-6Regenerative Medicine Market
- Track 7-7Stem Cell Pellets/Sheets In Regenerative Therapy
- Track 7-8Hair Follicle Stem Cells In Regeneration
Tissue engineering can be defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions in an effort to improve clinica l procedures for the repair of damaged tissues and organs.
- Track 8-1Trends In Tissue Engineering
- Track 8-2Applications In Tissue Engineering
- Track 8-3Scaffolds In Regenerative Medicine
- Track 8-4Tissue Repair And Regeneration
- Track 8-5Stem Cells Progress In In situ Revascularization And Grafting
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition.The most well-established and widely used stem cell treatment is the transplantation of blood stem cells to treat diseases and conditions of the blood and immune system, or to restore the blood system after treatments for specific cancers.
- Track 9-1Autoimmune Disease Stem Cell Treatment
- Track 9-2Blood And Skin Diseases
- Track 9-3Organ Cancer: Gastric cancer, Breast, Oral, Head And Neck Cancer
- Track 9-4Lymphoma
- Track 9-5Alzheimers And Stem Cells
- Track 9-6Periodontal Diseases And Stem Cells
In recognition to the enormous potential of stem cell research, stem cells have proven to be powerful tool in modern biomedical research.
- Track 10-1Recent Developments In Pre-Clinical And Clinical Trials of Stem Cell Therapy
- Track 10-2Screening New Compounds And Identifying More Effective Medicines
- Track 10-3Challenges And Status of Currently Viable Companies
- Track 10-4Funding And Regulatory Challenges
Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem cells are defined as totipotent progenitor cells capable of self renewal and multilineage differentiation. Stem cells survive well and show stable division in culture, making them ideal targets for in vitro manipulation.
- Track 11-1Assay Marks Excellence in Cell Line Quality
- Track 11-2Stem Cell Embryonic Vascular Development
Computational biology, a branch of biology involving the application of computers and computer science to the understanding and modeling of the structures and processes of life. It entails the use of computational methods for the representation and simulation of biological systems, as well as for the interpretation of experimental data, often on a very large scale. The fields of stem cell biology and regenerative medicine research are fundamentally about understanding dynamic cellular processes such as development, reprogramming, repair, differentiation and the loss, acquisition or maintenance of pluripotency. In order to precisely decipher these processes at a molecular level, it is critical to identify and study key regulatory genes and transcriptional circuits. Modern high-throughput molecular profiling technologies provide a powerful approach to addressing these questions as they allow the profiling of tens of thousands of gene products in a single experiment. Whereas bioinformatics is used to interpret the information produced by such technologies.
- Track 12-1Computational Biomodeling
- Track 12-2Computational Evolutionary Biology
- Track 12-3Cancer Computational Biology
- Track 12-4Bioinformatics Analysis of Stem Cells
- Track 12-5Cellular Computing And Drug Discovery
Translational research involves future clinical application of the ongoing stem cell studies.
- Track 13-1Neural stem cells , Neurogenesis And Brain Maturation
- Track 13-2Advances In Craniomaxillofacial Applications
- Track 13-3Stem Cell Therapy In Diabetes
- Track 13-4Stem Cell Therapy In Neurodegenerative Diseases
- Track 13-5Application of Stem Cells In Heart Diseases
- Track 13-6Applications of Stem Cells In Urology
- Track 13-7Stem Cells In Orthopedic Treatments
- Track 13-8Stem cells In Hair Regrowth Therapies
Cancer cells are cells gone wrong in other words, they no longer respond to many of the signals that control cellular growth and death. Cancer cells originate within tissues and, as they grow and divide, they diverge ever further from normalcy. Over time, these cells become increasingly resistant to the controls that maintain normal tissue and as a result, they divide more rapidly than their progenitors and become less dependent on signals from other cells. Cancer cells even evade programmed cell death, despite the fact that their multiple abnormalities would normally make them prime targets for apoptosis. In the late stages of cancer, cells break through normal tissue boundaries and metastasize to new sites in the body
- Track 15-1Therapeutic Target For Cancer
- Track 15-2Hormone Therapies
- Track 15-3Histology
- Track 15-4Pathology
- Track 15-5Cancer Stem Cells And Drug Resistance
An amniotic stem cell bank is a facility that stores stem cells derived from amniotic fluid for future use. Stem cell samples in private banks are stored specifically for use by the individual person from whom such cells have been collected and the banking costs are paid by such person.
- Track 16-1Amniotic Stem Cell Bank
- Track 16-2Umbilical Cord Blood Banks
- Track 16-3Hematopoietic Stem Cell And Potential Non-Hematopoietic And Stem Cells
Stem cell plasticity refers to the ability of some stem cells to give rise to cell types, formerly considered outside their normal repertoire of differentiation for the location where they are found. Included under this umbrella title is often the process of “transdifferentiation” – the conversion of one differentiated cell type into another, and metaplasia – the conversion of one tissue type into another.
- Track 17-1Epithelial To Mesenchymal Plasticity And Stem Cells
- Track 17-2Tissue Repair
- Track 17-3Mechanism of Cellular Plasticity
- Track 17-4Adaptive Cellular Reprogramming
The study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself. Epigenetics are stable heritable traits that cannot be explained by changes in DNA sequence.
- Track 18-1Bone Remodeling And Osteoporosis
- Track 18-2Single-cell Technology In Cancer Research
- Track 18-3Stem Cell Epigenetics And Disease
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient’s cells instead of using drugs or surgery.
- Track 19-1Somatic Cell Nuclear Transfer (SCNT)
- Track 19-2Gene Therapy and Genetic Engineering
- Track 19-3Somatic Gene Therapy
- Track 19-4Germ Line Gene Therapy
- Track 19-5Cell Cancer Immunotherapy
Stem cell markers are genes and their protein products used by scientists to isolate and identify stem cells. Stem cells can also be identified by functional assays. Molecular biomarkers serve as valuable tools to classify and isolate embryonic stem cells (ESCs) and to monitor their differentiation state by antibody-based techniques. ESCs can give rise to any adult cell type and thus offer enormous potential for regenerative medicine and drug discovery.
- Track 20-1Stem Cell Markers
- Track 20-2Biomarkers And Cancers
- Track 20-3Organ Cancer: Pancreatic Cancer, Colorectal Cancer, Breast , Oral, Head And Neck Cancer
- Track 20-4Cancer Therapeutics
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.
- Track 21-1Reprogramming And Creating Stem Cells
- Track 21-2Regenerative Approaches With Nanoparticles
- Track 21-3Decellularization
- Track 21-4Blastocyst Complementation
- Track 21-5Advanced Developments In Artificial Organ System
Stem-cell niche refers to a microenvironment, within the specific anatomic location where stem cells are found, which interacts with stem cells to regulate cell fate. The word 'niche' can be in reference to the in vivo or in vitro stem-cell microenvironment.During embryonic development, various niche factors act on embryonic stem cells to alter gene expression, and induce their proliferation or differentiation for the development of the fetus.
- Track 22-1Invivo Stem Cell Microenvironment
- Track 22-2Embryonic Erythropoietic Niche
- Track 22-3Atrial Cardiac Stem Cells Niche
- Track 22-4Germline Stem Cell Niches
- Track 22-5Adult Stem Cell Niches
- Track 22-6Mesenchymal Stem Cells And Immunomodulation
The clinical development plan is a complex document that entails the entire clinical research strategy of a drug, describing the clinical studies that will be carried out for a pharmaceutical entity, created by a pharmaceutical company.
- Track 23-1Drug-Loaded Polymeric Nanoparticles Stem Cells
- Track 23-2Stem Cell Role In Toxicity Testing
- Track 23-3Autologus MSCs In Veterinary Applications
The stem cell field in veterinary medicine continues to evolve rapidly both experimentally and clinically. Stem cells are most commonly used in clinical veterinary medicine in therapeutic applications for the treatment of musculoskeletal injuries in horses and dogs. New technologies of assisted reproduction are being developed to apply the properties of spermatogonial stem cells to preserve endangered animal species.same methods can be used to generate transgenic animals for production of pharmaceuticals or for use as biomedical models
- Track 24-1Cell Based Therapy In Veterinary Medicine
- Track 24-2Bio Science And Clinical Applications of Stem Cells In Veterinary Medicine
- Track 24-3Stem Cells And Regeneration In Veterinary Science
Cell physiology including cellular electrophysiology is the biological study of the activities which take place in a cell to keep it alive. The term "physiology" refers to all the normal functions that take place in a living organism. Absorption of water by roots, production of food in the leaves, and growth of shoots towards light are examples of plant physiology. The heterotrophic metabolism of food derived from plants and animals and the use of movement to obtain nutrientsare characteristic of animal physiology.
- Track 25-1Molecular And Genetic Basis of Plant-Insect Interaction
- Track 25-2Plant Pathology
- Track 25-3Plant Genomics Applications
- Track 25-4Plant Stem Cells
- Track 25-5Plant Genomics In World Economy
- Track 25-6Agrotechnology
- Track 25-7Seed Genomic
A disease model is an animal or cells displaying all or some of the pathological processes that are observed in the actual human or animal disease. Studying disease models aids understanding of how the disease develops and testing potential treatment approaches.
- Track 26-1Astrocyte Differentiation And Stem Cells
- Track 26-2Modeling Human Disease With Pluripotent Stem Cells
- Track 26-3Adult Stem cells And Embryonic Stem Cells In Disease Modelling
- Track 26-4Induced Pluripotent Stem Cells Greatest Utility For Disease Modelling
The regulation of stem cell research is an issue that has drawn much comment, criticism and even judicial arbitration in recent years.
- Track 27-1Ethical Issues In Stem Cell Research
- Track 27-2Key Ethical Issues In Embryonic Stem Cell
- Track 27-3IPR
- Track 27-4Biosafety And rDNA Guidelines
- Track 27-5Governing Stem Cell Therapy And Fundings